National Health Investors (NYSE: NHI) reported Q3 EPS of $0.65, $0.08 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $82.94 million versus the consensus estimate of $68.05 million.
Guidance 2024:

NFFO per diluted common share: $4.43- $4.44

For earnings history and earnings-related data on National Health Investors (NHI) click here.